Viewing Study NCT00115050


Ignite Creation Date: 2025-12-24 @ 5:23 PM
Ignite Modification Date: 2026-02-05 @ 6:48 AM
Study NCT ID: NCT00115050
Status: COMPLETED
Last Update Posted: 2011-06-10
First Post: 2005-06-20
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: TMC114-C209: A Study of Safety of TMC114 With Low Dose Ritonavir (RTV) and Other Antiretrovirals in Experienced HIV-1 Infected Patients With Limited or no Treatment Options
Sponsor: Tibotec Pharmaceuticals, Ireland
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None HIV Infections View
Keywords:

Keywords

Keyword Brief Keyword Text View
None HIV infections View
None Antiretroviral View
None TMC114 View
None Ritonavir View
None Safety, TMC114-C209 View